Precision Biosciences (DTIL) Net Cash Flow (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -117.15% |
| Dec 31, 2025 | 585.07% |
| Sep 30, 2025 | 9.27% |
| Jun 30, 2025 | -72.64% |
| Mar 31, 2025 | 32.51% |
| Dec 31, 2024 | -473.34% |
| Sep 30, 2024 | 84.20% |
| Jun 30, 2024 | -167.31% |
| Mar 31, 2024 | 479.76% |
| Dec 31, 2023 | 64.32% |
| Sep 30, 2023 | 23.48% |
| Jun 30, 2023 | 35.32% |
| Mar 31, 2023 | -39.91% |
| Dec 31, 2022 | -180.51% |
| Sep 30, 2022 | -58.89% |
| Jun 30, 2022 | 347.49% |
| Mar 31, 2022 | -63.26% |
| Dec 31, 2021 | -24.76% |
| Sep 30, 2021 | 30.97% |
| Jun 30, 2021 | -118.83% |
| Mar 31, 2021 | 822.38% |
| Dec 31, 2020 | 36.89% |
| Sep 30, 2020 | 16.71% |
| Jun 30, 2020 | -2.25% |
| Mar 31, 2020 | -5.20% |
| Dec 31, 2019 | -27.96% |
| Sep 30, 2019 | -118.10% |
| Jun 30, 2019 | 723.69% |
| Mar 31, 2019 | 154.59% |
| Dec 31, 2018 | -1,195.51% |
| Sep 30, 2018 | -97.13% |
| Jun 30, 2018 | 615.47% |